Abbott RealTime CMV

Cytomegalovirus (cmv) Dna Quantitative Assay

FDA Premarket Approval P160044 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Implement additional qc to device accessory kits.

DeviceAbbott RealTime CMV
Classification NameCytomegalovirus (cmv) Dna Quantitative Assay
Generic NameCytomegalovirus (cmv) Dna Quantitative Assay
ApplicantABBOTT MOLECULAR
Date Received2019-04-10
Decision Date2019-05-15
PMAP160044
SupplementS002
Product CodePAB
Advisory CommitteeMicrobiology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT MOLECULAR 1300 East Touhy Avenue des Plaines, IL 60018

Supplemental Filings

Supplement NumberDateSupplement Type
P160044Original Filing
S005 2022-12-20 30-day Notice
S004 2022-05-19 30-day Notice
S003 2021-02-05 30-day Notice
S002 2019-04-10 30-day Notice
S001 2017-06-27 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00884999047297 P160044 000
00884999045798 P160044 000
00884999045781 P160044 000
00884999045774 P160044 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.